SCHEMBL13184426

SCHEMBL13184426

Cc1cc(C(=O)c2c(F)c(C)nn2C)ccn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 1/20 0.37
▸ SPR P35270 3/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ PROKR1 Q8TCW9 3/20 0.35
▸ KCNT1 Q5JUK3 1/20 0.34
▸ JMJD6 Q6NYC1 3/20 0.34
▸ CSNK1D P48730 1/20 0.34
▸ CSNK1E P49674 1/20 0.34
▸ TTR P02766 1/20 0.33
▸ CCR9 P51686 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ KDM5A P29375 2/20 0.33
▸ KDM4C Q9H3R0 2/20 0.33
▸ KDM5B Q9UGL1 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ENPP3 O14638 1/20 0.33
▸ ALPL P05186 1/20 0.33
▸ XIAP P98170 1/20 0.33
▸ UHRF1 Q96T88 1/20 0.33
▸ WNT1 P04628 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13184425 0.78 ALDH1A1 (0.44) SPRL3MBTL1POLBKDM4E
SCHEMBL13683131 0.78 GRM5 (0.42) GRM5PROKR1KCNT1JMJD6CSNK1D
SCHEMBL3356107 0.75 UHRF1 (0.50) PROKR1CCR9KDM5AKDM4CKDM5B
SCHEMBL13184401 0.74 KDM4E (0.39) GRM5PROKR1KCNT1JMJD6CCR9
SCHEMBL13683178 0.73 KMT2A (0.45) L3MBTL1KDM4EGSK3B
SCHEMBL13184263 0.72 BAZ2B (0.47) L3MBTL1PROKR1JMJD6CCR9POLB
SCHEMBL16200404 0.69 POLB (0.43) GRM5PROKR1JMJD6CCR9POLB
SCHEMBL16200174 0.69 DYRK1A (0.41) GRM5KCNT1CSNK1DCSNK1EPOLB
SCHEMBL13683180 0.68 KDM4E (0.41) L3MBTL1KDM4E
SCHEMBL19556155 0.68 L3MBTL1 (0.42) L3MBTL1TTRPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8324216-B2 Substituted piperazines CHEMOCENTRYX, INC. (US) 2012-12-04 — — US disclosed
US-20100240618-A1 SUBSTITUTED PIPERAZINES CHEMOCENTRYX, INC. (US) 2010-09-23 — — US disclosed
US-7589199-B2 Substituted piperazines CHEMOCENTRYX, INC. (US) 2009-09-15 — — US disclosed
US-7435830-B2 Bicyclic and bridged nitrogen heterocycles CHEMOCENTRYX, INC. (US) 2008-10-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240618-A1 SUBSTITUTED PIPERAZINES CCR1, CCR3, CCRL2 GRM5 177/4885SPR 2083/4885L3MBTL1 1589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback